Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: Data from the capsure database

Journal of Urology

Volumn 163, Issue 4, 2000, Pages 1171-1177

  Grossfeld, Gary D ^a   Chang, James J ^a   Broering, Jeanette M ^a   Miller, Dave P ^a   Yu, Jenny ^a   Flanders, Scott C ^a   Henning, James M ^a   Stier, David M ^a   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Prognosis; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; DATA BASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY;

EID: 0034023029     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67716-6     Document Type: Article

References (26)

1. Epstein, J. I.: Incidence and significance of positive margins in radical prostatectomy specimens. Urol Clin North Am, 23: 651, 1996
2. Partin, A. W., Kattan, M. W., Subong, E. N. et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA, 277: 1445, 1997
3. Stamey, T. A., McNeal, J. E., Yemoto, C. M. et al: Biological determinants of cancer progression in men with prostate cancer. JAMA, 281: 1395, 1999
4. Kattan, M. W., Eastham, J. A., Stapleton, A. M. et al: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst, 90: 766, 1998
5. Stamey, T. A., Villers, A. A., McNeal, J. E. et al: Positive surgical margins at radical prostatectomy: importance of the apical dissection. J Urol, 143: 1166, 1990
6. Smith, R. C., Partin, A. W., Epstein, J. I. et al: Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. J Urol, 156: 454, 1996
7. Blute, M. L., Bostwick, D. G., Bergstralh, E. J. et al: Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology, 50: 733, 1997
8. D'Amico, A. V., Whittington, R., Malkowicz, S. B. et al: A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol, 154: 131, 1995
9. Epstein, J. I., Pizov, G. and Walsh, P. C.: Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, 71: 3582, 1993
10. Epstein, J. I., Partin, A. W., Sauvageot, J. et al: Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol, 20: 286, 1996
11. Epstein, J. I., Carmichael, M. J., Pizov, G. et al: Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol, 150: 135, 1993
12. Epstein, J. I., Pound, C. R., Partin, A. W. et al: Disease progres-sion following radical prostatectomy in men with Gleason score 7 tumor. J Urol, 160: 97, 1998
13. Ohori, M., Wheeler, T. M., Kattan, M. W. et al: Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol, 154: 1818, 1995
14. Paulson, D. F.: Impact of radical prostatectomy in the management of clinically localized disease. J Urol, part 2, 152: 1826, 1994
15. van den Ouden, D., Bentvelsen, F. M., Boevé, E. R. et al: Positive margins after radical prostatectomy: correlation with local recurrence and distant progression. Br J Urol, 72: 489, 1993
16. Lubeck, D. P., Litwin, M. S., Henning, J. M. et al: The CaPSURE™ database: a methodology for clinical practice and research in prostate cancer. CaPSURE™ Research Panel, Cancer of the Prostate Strategic Urologic Research Endeavor. Urology, 48: 773, 1996
17. Prostate. In: Manual for Staging of Cancer, American Joint Committee on Cancer, 4th ed. Edited by O. H. Beahrs, D. E. Henson, R. V. P. Hutter et al. Philadelphia: J. B. Lippincott, chapt. 31, pp. 181-186, 1992
18. Bartko, J. J.: The intraclass correlation coefficient as a measure of reliability. Psychol Rep, 19: 3, 1966
19. Fisher, R. A.: Statistical Methods for Research Workers. Edinburgh: Oliver and Boyd, 1944
20. Fesseha, T., Sakr, W., Grignon, D. et al: Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol, 158: 2176, 1997
21. Lowe, B. A. and Lieberman, S. F.: Disease recurrence and progression in untreated pathologic stage T3 prostate cancer: selecting the patient for adjuvant therapy. J Urol, 158: 1452, 1997
22. Bauer, J. J., Connelly, R. R., Sesterhenn, I. A. et al: Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy. Cancer, 79: 952, 1997
23. Fowler, F. J., Jr., Barry, M. J., Lu-Yao, G. L. et al: Outcomes of external-beam radiation therapy for prostate cancer: a study -of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol, 14: 2258, 1996
24. Grossfeld, G. D., Stier, D. M., Flanders, S. C. et al: Use of second treatment following definitive local therapy for prostate cancer: data from the CaPSURE database. J Urol, 160: 1398, 1998
25. Lu-Yao, G. L., Potosky, A. L., Albertsen, P. C. et al: Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Cancer Inst, 88: 166, 1996
26. D'Agostino, R. B. and Kwan, H.: Measuring effectiveness. What to expect without a randomized control group. Med Care, suppl. 1, 33: AS95, 1995